Back to search

University of Strathclyde

End-to-end optimization of lipid nanoparticle manufacturing for mRNA delivery

Abstract

dc:description.abstract

With the emergence of SARS-CoV-2 in 2020, mRNA vaccines have gained global attention. Currently,lipid nanoparticles (LNPs) are the most clinically advanced drug delivery system for the delivery ofnucleic acids. Despite the extensive literature on LNPs in recent years, challenges persist regardingtheir development and production. In fact, most research papers focus on the therapeutic targets ofLNPs, while less attention is given to understanding the challenges associated with theirmanufacturing, especially on an industrial-production scale, including scalability, reproducibility,encapsulation efficiency and long-term storage.This thesis focused on the end-to-end workflow of LNPs manufacturing, covering production,purification, and freeze-drying, while also addressing storage conditions. Beginning with LNPproduction, the effects of microfluidic parameters on LNP manufacturing were investigated while thepreclinical scalable production of LNPs using various microfluidic devices was also evaluated. Movingon to purification, the second step of LNP manufacturing, the typical bottlenecks associated with thisstage were assessed, with a focus on tangential flow filtration (TFF) as this method is commonly usedon an industrial level. The effect of TFF speed and diafiltration volumes on LNPs characteristics wereevaluated, along with the challenges related to scaling up the purification process. mRNA LNPs storagealso represents a challenge due to the fragile nature of mRNA. With the aim of exploring lyophilisationas a technique for preserving mRNA LNPs, a series of freeze-drying cycles were conducted to identifythe optimal parameters for producing mRNA LNPs with acceptable critical quality attributes (CQAs)and the in vitro and in vivo activity of the lyophilised product was evaluated to determine theeffectiveness of the method. This thesis also explored the role of lipid selection in shaping the quality,stability, and performance of the final product. In particular, the contribution of PEGylated lipids havingdifferent alkyl chain lengths (DMG-PEG 2000 versus DSG-PEG 2000) to the physicochemicalcharacteristics and performance of mRNA LNPs was investigated, as well as the impact in vitro and invivo of the ionisable lipid (ALC-0315, DLin-MC3, and SM-102).The results presented demonstrate that all steps of LNP manufacturing influence the CQAs of theparticles, from the choice of lipids, which can either limit or enhance their efficiency, to the selectionof microfluidic parameters, buffers, purification methods, and lyophilisation conditions, highlightingthe importance of carefully considering each individual step.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Giacobbo, Valeria
Advisor dc:contributor.advisor
  • Perrie, Yvonne
Author Identifier dc:creator.authoridentifier
  • 202291971

Rights

Identifiers

dc:identifier.*
Identifier
T17308

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Giacobbo, Valeria. End-to-end optimization of lipid nanoparticle manufacturing for mRNA delivery. doctoral-pg thesis, University of Strathclyde, 2025. https://stax.strath.ac.uk/concern/theses/vx021f609